Cogent Biosciences, Inc. (COGT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 877.8M | 910.36M | 397.24M | 245.01M | 252.88M | 296.47M | 341.53M | 369.97M | 441.9M | 270.77M | 285.95M | 334.52M |
| Cash & Short-Term Investments | 866.38M | 900.76M | 390.89M | 237.85M | 245.66M | 287.08M | 335.52M | 363.22M | 435.74M | 265.71M | 279.04M | 329.4M |
| Cash Only | 241.21M | 312.01M | 125.3M | 127.6M | 126M | 98.17M | 97.05M | 88.22M | 215.8M | 53.23M | 86.81M | 214.32M |
| Short-Term Investments | 625.17M | 588.75M | 265.59M | 110.25M | 119.66M | 188.91M | 238.47M | 275M | 219.94M | 212.48M | 192.23M | 115.08M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 11.43M | 9.59M | 0 | 7.16M | 7.22M | 9.39M | 6.01M | 6.75M | 6.16M | 5.06M | 6.91M | 5.12M |
| Total Non-Current Assets | 25.2M | 27.25M | 28.69M | 29.81M | 30.91M | 31.43M | 42.49M | 59.96M | 34.21M | 42.67M | 69.49M | 57.85M |
| Property, Plant & Equipment | 22.85M | 23.54M | 23.86M | 24.95M | 26.05M | 26.56M | 27.6M | 28.41M | 29.35M | 30.34M | 30.84M | 31.56M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 416K | 0 | 0 | 0 | 0 | 0 | 10.03M | 26.69M | 0 | 7.46M | 33.79M | 21.51M |
| Other Non-Current Assets | 1.94M | 3.72M | 4.82M | 4.86M | 4.86M | 4.86M | 4.86M | 4.86M | 4.86M | 4.86M | 4.86M | 4.78M |
| Total Assets | 903.01M | 937.61M | 425.93M | 274.82M | 283.8M | 327.9M | 384.02M | 429.94M | 476.11M | 313.44M | 355.45M | 392.37M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 218.19% | 185.94% | 10.92% | -36.08% | -40.39% | 4.61% | 8.04% | 9.57% | 80.89% | 4.2% | 7.2% | 7.19% |
| Total Current Liabilities | 57.98M | 63.95M | 62.25M | 58.42M | 49.32M | 55.71M | 53.05M | 40M | 36.69M | 38.17M | 34.72M | 25.76M |
| Accounts Payable | 13.74M | 9.5M | 16.03M | 16.63M | 14.15M | 12.01M | 15.06M | 8.97M | 15.56M | 10.65M | 9.87M | 7.16M |
| Days Payables Outstanding | 905.77 | 997.89 | - | 1.21K | - | - | - | - | - | - | - | - |
| Short-Term Debt | 1.38M | 1.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 36.65M | 52.9M | 1.28M | 9.4M | 4.15M | 12.63M | 36.47M | 5.93M | 3.07M | 10.31M | 6.33M | 5.25M |
| Current Ratio | 15.14x | 14.23x | 6.38x | 4.19x | 5.13x | 5.32x | 6.44x | 9.25x | 12.05x | 7.09x | 8.24x | 12.99x |
| Quick Ratio | 15.14x | 14.23x | 6.38x | 4.19x | 5.13x | 5.32x | 6.44x | 9.25x | 12.05x | 7.09x | 8.24x | 12.99x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 237.33M | 237.28M | 61.22M | 61.36M | 15.48M | 15.9M | 16.31M | 16.71M | 17.09M | 17.47M | 17.83M | 18.18M |
| Long-Term Debt | 223.17M | 237.25M | 44.25M | 43.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 14.1M | 14.36M | 14.6M | 15.05M | 15.48M | 15.9M | 16.31M | 16.71M | 17.09M | 17.47M | 17.83M | 18.18M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 62K | -14.32M | 2.37M | 2.36M | 5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 295.31M | 301.24M | 123.47M | 119.78M | 64.8M | 71.61M | 69.36M | 56.71M | 53.78M | 55.63M | 52.55M | 43.94M |
| Total Debt | 238.65M | 253.15M | 60.56M | 60.66M | 17.09M | 17.47M | 17.83M | 18.18M | 18.52M | 18.85M | 19.17M | 19.36M |
| Net Debt | -2.56M | -58.86M | -64.74M | -66.94M | -108.91M | -80.7M | -79.22M | -70.03M | -197.28M | -34.38M | -67.64M | -194.96M |
| Debt / Equity | 0.39x | 0.40x | 0.20x | 0.39x | 0.08x | 0.07x | 0.06x | 0.05x | 0.04x | 0.07x | 0.06x | 0.06x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -85.41x | -82.04x | -54.47x | -233.17x | - | - | - | - | - | - | - | - |
| Total Equity | 607.69M | 636.37M | 302.46M | 155.04M | 219M | 256.29M | 314.66M | 373.22M | 422.33M | 257.8M | 302.9M | 348.43M |
| Equity Growth % | 177.49% | 148.31% | -3.88% | -58.46% | -48.15% | -0.59% | 3.88% | 7.12% | 88.91% | 0.81% | 4.47% | 9.09% |
| Book Value per Share | 9.01 | 9.41 | 2.64 | 1.35 | 1.93 | 2.32 | 2.86 | 3.76 | 4.45 | 2.97 | 3.52 | 4.66 |
| Total Shareholders' Equity | 607.69M | 636.37M | 302.46M | 155.04M | 219M | 256.29M | 314.66M | 373.22M | 422.33M | 257.8M | 302.9M | 348.43M |
| Common Stock | 171K | 161K | 141K | 114K | 114K | 110K | 110K | 109K | 96K | 86K | 86K | 85K |
| Retained Earnings | -1.29B | -1.19B | -1.09B | -1B | -931.47M | -859.48M | -791.56M | -720.92M | -661.97M | -603.62M | -549.26M | -493.88M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -415K | 355K | 208K | 13K | 164K | 447K | 896K | -192K | -39K | 246K | -172K | -97K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |